Cas:133407-82-6 Calpain Inhibitor IV manufacturer & supplier

Chemical Name:Calpain Inhibitor IV

CAS.NO:133407-82-6

Synonyms:benzyloxycarbonyl-Leu-Leu-Leu-aldehyde;L-Leucinamide, N-((phenylmethoxy)carbonyl)-L-leucyl-N-((1S)-1-formyl-3-methylbutyl)-;Z-LLL-CHO;benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate;MG132;zLLL;Z-Leu-Leu-Leu-CHO;Cbz-Leu-Leu-Leu-H;L-Leucinamide, N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-;N-[(Benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide;Z-Leu-Leu-Leu-H;benzyloxycarbonylleucyl-leucyl-leucine aldehyde;benzyloxycarbonyl-leucyl-leucyl-leucinal;Z-Leu-Leu-leucinal;N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal;MFCD00674886;Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal;Cbz-Leu-Leu-Leu-CHO;N-[(Benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxo-2-pentanyl]-L-leucinamide;MG-132

Molecular Formula:C₂₆H₄₁N₃O₅

Molecular Weight:475.621

HS Code:

Physical and Chemical Properties:

Melting point:80-84℃ (DEC.)

Boiling point:682.0±55.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.506

PSA:113.60000

Exact Mass:475.304626

LogP:5.75

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like benzyloxycarbonyl-Leu-Leu-Leu-aldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MG-132 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzyloxycarbonylleucyl-leucyl-leucine aldehyde Use and application,L-Leucinamide, N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]- technical grade,usp/ep/jp grade.

Related News: The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. [Re(2,2′-bipyridine)(CO)3(P(O-i-Pr)3)](PF6) manufacturers And finally, CHMP also concluded its investigation into bluebird bio’s Zynteglo, finding no evidence that it causes a blood cancer known as acute myeloid leukemia. 1-(3-methoxyphenethyl)-4-(2-methoxyphenyl)piperazine dihydrochloride suppliers EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML). 1-Piperidinepentanoic acid, hydrochloride vendor & factory Biocatalytic processing offers many advantages over using conventional metal catalysts. The superior enantio- and regioselectivity of enzymes results in higher yields of purer product—typically comprising just a single enantiomer that has been modified on only a specific site. ,The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients.